Abstract:Y. Ai, S. Wu, H. Gao, H. Wei, Z. Tang, X. Li, and C. Zou, "Repression of CRNDE Enhances the Anti-Tumour Activity of CD8+ T Cells Against Oral Squamous Cell Carcinoma Through Regulating Mir-545-5p and TIM-3," Journal of Cellular and Molecular Medicine 25, no. 23 (2021): 10857-10868, https://doi.org/10.1111/jcmm.16909. The above article, published online on 02 November 2021 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Stefan Constantinescu; The Foundation for Cellular and Molecular Medicine; and John Wiley and Sons Ltd. The retraction has been agreed following an investigation into concerns raised by a third party, which revealed inappropriate duplications of image panels (Figures 4C,D, 6B and 7B) between this and other articles that were previously published in a different scientific context. The authors were unable to provide a satisfactory explanation, and the provided raw data could not explain the identified issues. Thus, the editors consider the conclusions of this manuscript substantially compromised. The authors were informed of the decision to retract but did not respond to the retraction decision or the wording.

Reduced Mir-363-3p Expression in Non-Small Cell Lung Cancer is Associated with Gemcitabine Resistance Via Targeting of CUL4A.

MiR-30 Suppresses Lung Cancer Cell 95D Epithelial Mesenchymal Transition and Invasion Through Targeted Regulating Snail.

Circ0021205 Aggravates the Progression of Non-Small Cell Lung Cancer by Targeting Mirna-16-5p/vegfa

RETRACTED: Mir-539 Enhances Chemosensitivity to Cisplatin in Non-Small Cell Lung Cancer by Targeting DCLK1

[Retracted] MicroRNA‑874 Inhibits Growth, Induces Apoptosis and Reverses Chemoresistance in Colorectal Cancer by Targeting X‑linked Inhibitor of Apoptosis Protein

Retracted: Long Non‐coding RNA TP73‐AS1 Facilitates Progression and Radioresistance in Lung Cancer Cells by the Mir‐216a‐5p/cul4b Axis with Exosome Involvement

Retraction Note: Decreased Expression of Mir-939 Contributes to Chemoresistance and Metastasis of Gastric Cancer Via Dysregulation of SLC34A2 and Raf/MEK/ERK Pathway

Retraction: Mir-1266 Suppresses The Growth And Metastasis Of Prostate Cancer Via Targeting Prmt5 (Retraction Of Vol 23, Pg 6436, 2019)

[Retracted] Tumor suppressor miR‐613 induces cisplatin sensitivity in non‐small cell lung cancer cells by targeting GJA1

[Retracted] Mir‑218 Suppresses Tumor Growth and Enhances the Chemosensitivity of Esophageal Squamous Cell Carcinoma to Cisplatin

Retracted: A Regulatory Axis of Circ_0008193/mir-1180-3p/trim62 Suppresses Proliferation, Migration, Invasion, and Warburg Effect in Lung Adenocarcinoma Cells under Hypoxia

RETRACTION: Repression of CRNDE Enhances the Anti-Tumour Activity of CD8 + T Cells Against Oral Squamous Cell Carcinoma Through Regulating Mir-545-5p and TIM-3

Retracted: miR-339-5p Inhibits Autophagy to Reduce the Resistance of Laryngeal Carcinoma on Cisplatin via Targeting TAK1

Retraction: LBX2-AS1 promotes ovarian cancer progression by facilitating E2F2 gene expression via Mir-455-5p and Mir-491-5p sponging

[Retracted] miR‐133b induces chemoresistance of osteosarcoma cells to cisplatin treatment by promoting cell death, migration and invasion

Retraction Note: Exosome-transmitted Mir-128-3p Increase Chemosensitivity of Oxaliplatin-Resistant Colorectal Cancer

[Retracted] MicroRNA‐219 is downregulated in non‐small cell lung cancer and inhibits cell growth and metastasis by targeting HMGA2

RETRACTED ARTICLE: Mir-135 Promotes Proliferation and Stemness of Oesophageal Squamous Cell Carcinoma by Targeting RERG

[Retracted] Glutathione peroxidase 2 overexpression promotes malignant progression and cisplatin resistance of KRAS‐mutated lung cancer cells

[Retracted] Targeting of TLE3 by miR‐3677 in human breast cancer promotes cell proliferation, migration and invasion

Retracted: mir-126-5p Promotes Cisplatin Sensitivity of Non-Small-Cell Lung Cancer by Inhibiting ADAM9